Kevin White maps the gene networks that control development, disease, and evolution. His work combines technology development, genome science, computation and engineering. His lab focuses on discovering genetic factors that contribute to complex diseases such as cancer and neuropsychiatric disorders. Much of this work involves building genome-wide models of transcriptional networks and the cellular states they control.
White and his team have contributed to the human ENCODE project, the PsychENCODE project, the Cancer Genome Atlas, and the Genomic Data Commons. At the University of Chicago he also led the Chicago Pancreatic Cancer Initiative that seeks to use genomics and data science to develop individualized treatment plans that provide the most effective therapies for a person’s cancer while minimizing side effects.
As a leading translational scientist in the field of precision medicine, White seeks to apply new discoveries to develop practical solutions for treating human disease. Presently he is on sabbatical from University of Chicago at the precision medicine company Tempus Labs, Inc. where he is President and leads a team of over 100 scientists.
White has been honored as a National Institutes of Health Genome Scholar, a W. M. Keck Distinguished Young Investigator in Medical Sciences, and an Arnold and Mabel Beckman Young Investigator. He serves as an advisor on multiple boards including centers at Yale, Harvard and Northwestern University. He is also a member of the Board of Scientific Advisors for the National Cancer Institute.